CUSIP: M87245102
Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / ORD SHS
-
Total 13F shares
-
25,220,498
-
Share change
-
-795,853
-
Total reported value
-
$180,371,175
-
Price per share
-
$7.15
-
Number of holders
-
64
-
Value change
-
-$12,730,488
-
Number of buys
-
27
-
Number of sells
-
39
Quarterly Holders Quick Answers
What is CUSIP M87245102?
CUSIP M87245102 identifies ELOS - SYNERON MEDICAL LTD - ORD SHS in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2015
-
Previous quarter:
Q2 2015
Recent filing periods for CUSIP M87245102:
Institutional Holders of SYNERON MEDICAL LTD - ORD SHS (ELOS) as of Q3 2015
As of 30 Sep 2015,
SYNERON MEDICAL LTD - ORD SHS (ELOS) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,220,498 shares.
The largest 10 holders included
Senvest Management, LLC, NORTH TIDE CAPITAL, LLC, JPMORGAN CHASE & CO, DEERFIELD MANAGEMENT CO, DALTON GREINER HARTMAN MAHER & CO, SENZAR ASSET MANAGEMENT, LLC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, Broadfin Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
64
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.